ADC Therapeutics SA (ADCT) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ADC Therapeutics SA (ADCT)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.97

0.77%

After-hours Jan 06, 2025, 07:51 PM EST

ADC Therapeutics SA Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Jun 30, 2023	Mar 31, 2023
Product Revenue	18.02M	17.85M	373.00K	86.00K	39.00K
Product Revenue Growth	+0.94%	+4684.99%	+333.72%	+120.51%	n/a
Royalty Revenue Revenue	448.00K	205.00K	n/a	n/a	n/a
Royalty Revenue Revenue Growth	+118.54%	n/a	n/a	n/a	n/a

Revenue by Geography

Quarter	Dec 31, 2023
Emea Revenue	498.00K
Emea Revenue Growth	n/a
Japan Revenue	n/a
Japan Revenue Growth	n/a
United States Revenue	69.06M
United States Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Selling, General, and Administrative Revenue	20.68M	20.10M	22.58M	25.22M	23.09M	12.60M	30.49M	31.31M	36.46M	35.90M	37.38M	36.53M	33.63M	34.59M	31.49M	29.45M	20.27M	19.00M	8.51M	4.92M	2.30M	4.09M	3.30M	2.40M	2.40M	1.98M	1.98M
Selling, General, and Administrative Revenue Growth	+2.86%	-10.97%	-10.48%	+9.23%	+83.28%	-58.68%	-2.62%	-14.12%	+1.57%	-3.96%	+2.33%	+8.61%	-2.76%	+9.83%	+6.94%	+45.26%	+6.71%	+123.25%	+72.97%	+113.73%	-43.70%	+24.06%	+37.36%	n/a	+20.91%	n/a	n/a
Research and Development Revenue	32.50M	24.30M	25.73M	30.33M	28.44M	31.94M	39.48M	48.73M	41.68M	48.54M	48.95M	42.49M	36.80M	39.53M	39.17M	48.55M	32.16M	25.95M	35.38M	30.42M	30.54M	21.76M	23.29M	29.09M	29.09M	30.07M	30.07M
Research and Development Revenue Growth	+33.78%	-5.60%	-15.15%	+6.65%	-10.97%	-19.09%	-18.99%	+16.93%	-14.14%	-0.85%	+15.20%	+15.45%	-6.90%	+0.92%	-19.32%	+50.99%	+23.91%	-26.64%	+16.27%	-0.38%	+40.35%	-6.55%	-19.95%	n/a	-3.25%	n/a	n/a
Sales and Marketing Revenue	5.06M	4.85M	5.81M	9.28M	8.04M	8.33M	15.35M	16.18M	8.24M	9.26M	18.37M	18.60M	17.05M	15.22M	13.91M	9.35M	6.12M	4.00M	2.63M	n/a	n/a	n/a	n/a	-50.00K	-50.00K	50.00K	50.00K
Sales and Marketing Revenue Growth	+4.25%	-16.55%	-37.38%	+15.52%	-3.53%	-45.74%	-5.10%	+96.41%	-11.05%	-49.60%	-1.25%	+9.14%	+11.98%	+9.42%	+48.73%	+52.93%	+52.75%	+52.36%	n/a	n/a	n/a	n/a	-100.00%	n/a	-200.00%	n/a	n/a